{"id":35383,"date":"2023-10-14T13:36:35","date_gmt":"2023-10-14T13:36:35","guid":{"rendered":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/?p=35383"},"modified":"2023-10-14T13:36:35","modified_gmt":"2023-10-14T13:36:35","slug":"pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/","title":{"rendered":"Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine"},"content":{"rendered":"<div id=\"body-2a7ff6b3-718e-4776-99a2-195836fc12b1\" itemprop=\"articleBody\">\n            <span itemprop=\"author\" itemscope=\"\" itemtype=\"http:\/\/schema.org\/Organization\"><meta itemprop=\"name\" content=\"News Medical\"><meta itemprop=\"url\" content=\"https:\/\/www.news-medical.net\/\"><\/span><\/p>\n<p>Pfizer Australia and BioNTech SE today announced that the Therapeutic Goods Administration (TGA) have authorized the businesses\u2019 XBB.1.5-adapted monovalent COVID-19 vaccine (COMIRNATY<sup>\u00ae<\/sup> Omicron XBB.1.5) in individuals 5 years and older.<\/p>\n<p>Omicron XBB sublineages account for the vast majority of COVID-19 cases globally2. Although Omicron BA.4\/BA.5-adapted bivalent COVID-19 vaccines provide some protection against a variety of outcomes from XBB-related COVID-19,3,4 evidence suggests that vaccines higher matched to currently circulating strains may also help further improve protection against symptomatic and severe COVID-19.5<\/p>\n<blockquote>\n<p>We welcome the TGA\u2019s decision and commend them for his or her careful assessment of the most recent version of Comirnaty. This decision reaffirms our commitment to bring a high-quality vaccine against this virus to Australians.\u201d<\/p>\n<p style=\"text-align: right;\">Dr Krishan Thiru, Pfizer Australia &#038; Latest Zealand Medical Director<\/p>\n<\/blockquote>\n<p>\u201cIn 2022, COVID-19 was considered one of Australia\u2019s leading causes of death, behind heart disease and dementia.6 With today&#8217;s decision, an updated vaccine will shortly grow to be available that helps address multiple Omicron XBB-related sublineages, which currently account for the overwhelming majority of COVID-19 cases globally.\u201d<\/p>\n<p><!-- end mobile middle mrec --><\/p>\n<p>\u201cAs COVID-19 is anticipated to adopt a seasonal pattern, just like other respiratory viruses, we remain committed to providing COVID-19 vaccines which are which are higher matched to relevant circulating virus variants or sublineages to people worldwide,\u201d said Prof. Ugur Sahin, M.D., CEO and Co-founder of BioNTech. \u201cThe brand new variant-adapted monovalent vaccine goals to further improve protection against severe illness and hospitalization brought on by Omicron XBB descendent sublineages which are antigenically distant from prior Omicron strains.\u201d<\/p>\n<p>The TGA\u2019s decision was based on the total body of previous clinical, non-clinical, and real-world evidence supporting the security and <a href=\"https:\/\/www.news-medical.net\/health\/What-Does-Efficacy-Mean.aspx\" class=\"linked-term\">efficacy of<\/a> Pfizer and BioNTech\u2019s COVID-19 vaccines.<\/p>\n<p>The Australian Technical Advisory Group on Immunization (ATAGI) advises the Minister for\u00a0Health and Aged Care on the medical administration of vaccines available in Australia, including those available through the National Immunization Program (NIP).<\/p>\n<p>The usage of this vaccine must be in accordance with official recommendations.<\/p>\n<p>COVID-19 vaccines are freed from charge for Australians and can be found in pharmacies and general practices across Australia.<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer Australia and BioNTech SE today announced that the Therapeutic Goods Administration (TGA) have authorized the businesses\u2019 XBB.1.5-adapted monovalent COVID-19 vaccine (COMIRNATY\u00ae Omicron XBB.1.5) in individuals 5 years and older. Omicron XBB sublineages account for the vast majority of COVID-19 cases globally2. Although Omicron BA.4\/BA.5-adapted bivalent COVID-19 vaccines provide some protection against a variety of [&#8230;]\n","protected":false},"author":1,"featured_media":35384,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"fifu_image_url":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2017\/1\/A_doctor_makes_a_vaccination_to_a_child-Yuganov_Konstantin_cdbf1b05417f45e89b8268af4858e1c9-620x480.jpg","fifu_image_alt":"","two_page_speed":[],"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[97],"tags":[3943,3945,3941,3942,529,3948,3946,3940,3944,1284,3947],"class_list":["post-35383","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-announce","tag-approval","tag-australia","tag-biontech","tag-covid19","tag-monovalent","tag-omicron","tag-pfizer","tag-tga","tag-vaccine","tag-xbb-1-5adapted"],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine - Daniels Marketing BLC<\/title>\n<meta name=\"description\" content=\"Pfizer Australia and BioNTech SE today announced that the Therapeutic Goods Administration (TGA) have authorized the businesses\u2019 XBB.1.5-adapted\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine - Daniels Marketing BLC\" \/>\n<meta property=\"og:description\" content=\"Pfizer Australia and BioNTech SE today announced that the Therapeutic Goods Administration (TGA) have authorized the businesses\u2019 XBB.1.5-adapted\" \/>\n<meta property=\"og:url\" content=\"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/\" \/>\n<meta property=\"og:site_name\" content=\"Daniels Marketing BLC\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-14T13:36:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2017\/1\/A_doctor_makes_a_vaccination_to_a_child-Yuganov_Konstantin_cdbf1b05417f45e89b8268af4858e1c9-620x480.jpg\" \/>\n<meta name=\"author\" content=\"info\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2017\/1\/A_doctor_makes_a_vaccination_to_a_child-Yuganov_Konstantin_cdbf1b05417f45e89b8268af4858e1c9-620x480.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"info\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/10\\\/14\\\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/10\\\/14\\\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\\\/\"},\"author\":{\"name\":\"info\",\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/#\\\/schema\\\/person\\\/6a0a5d2e1a48d29297b62e635a4db33f\"},\"headline\":\"Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine\",\"datePublished\":\"2023-10-14T13:36:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/10\\\/14\\\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\\\/\"},\"wordCount\":363,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/10\\\/14\\\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/d2jx2rerrg6sh3.cloudfront.net\\\/image-handler\\\/picture\\\/2017\\\/1\\\/A_doctor_makes_a_vaccination_to_a_child-Yuganov_Konstantin_cdbf1b05417f45e89b8268af4858e1c9-620x480.jpg\",\"keywords\":[\"announce\",\"approval\",\"Australia\",\"BioNTech\",\"COVID19\",\"monovalent\",\"Omicron\",\"Pfizer\",\"TGA\",\"vaccine\",\"XBB.1.5adapted\"],\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/10\\\/14\\\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/10\\\/14\\\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\\\/\",\"url\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/10\\\/14\\\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\\\/\",\"name\":\"Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine - Daniels Marketing BLC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/10\\\/14\\\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/10\\\/14\\\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/d2jx2rerrg6sh3.cloudfront.net\\\/image-handler\\\/picture\\\/2017\\\/1\\\/A_doctor_makes_a_vaccination_to_a_child-Yuganov_Konstantin_cdbf1b05417f45e89b8268af4858e1c9-620x480.jpg\",\"datePublished\":\"2023-10-14T13:36:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/#\\\/schema\\\/person\\\/6a0a5d2e1a48d29297b62e635a4db33f\"},\"description\":\"Pfizer Australia and BioNTech SE today announced that the Therapeutic Goods Administration (TGA) have authorized the businesses\u2019 XBB.1.5-adapted\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/10\\\/14\\\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/10\\\/14\\\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/10\\\/14\\\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\\\/#primaryimage\",\"url\":\"https:\\\/\\\/d2jx2rerrg6sh3.cloudfront.net\\\/image-handler\\\/picture\\\/2017\\\/1\\\/A_doctor_makes_a_vaccination_to_a_child-Yuganov_Konstantin_cdbf1b05417f45e89b8268af4858e1c9-620x480.jpg\",\"contentUrl\":\"https:\\\/\\\/d2jx2rerrg6sh3.cloudfront.net\\\/image-handler\\\/picture\\\/2017\\\/1\\\/A_doctor_makes_a_vaccination_to_a_child-Yuganov_Konstantin_cdbf1b05417f45e89b8268af4858e1c9-620x480.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/10\\\/14\\\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/#website\",\"url\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/\",\"name\":\"Daniels Marketing BLC\",\"description\":\"All About Health &amp; Marketing\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/#\\\/schema\\\/person\\\/6a0a5d2e1a48d29297b62e635a4db33f\",\"name\":\"info\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/387c3341fa426df253347bf8f03bf81e7c8355f511b0ffdb256b6fad73bc149c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/387c3341fa426df253347bf8f03bf81e7c8355f511b0ffdb256b6fad73bc149c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/387c3341fa426df253347bf8f03bf81e7c8355f511b0ffdb256b6fad73bc149c?s=96&d=mm&r=g\",\"caption\":\"info\"},\"url\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/author\\\/info\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine - Daniels Marketing BLC","description":"Pfizer Australia and BioNTech SE today announced that the Therapeutic Goods Administration (TGA) have authorized the businesses\u2019 XBB.1.5-adapted","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/","og_locale":"en_US","og_type":"article","og_title":"Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine - Daniels Marketing BLC","og_description":"Pfizer Australia and BioNTech SE today announced that the Therapeutic Goods Administration (TGA) have authorized the businesses\u2019 XBB.1.5-adapted","og_url":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/","og_site_name":"Daniels Marketing BLC","article_published_time":"2023-10-14T13:36:35+00:00","og_image":[{"url":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2017\/1\/A_doctor_makes_a_vaccination_to_a_child-Yuganov_Konstantin_cdbf1b05417f45e89b8268af4858e1c9-620x480.jpg","type":"","width":"","height":""}],"author":"info","twitter_card":"summary_large_image","twitter_image":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2017\/1\/A_doctor_makes_a_vaccination_to_a_child-Yuganov_Konstantin_cdbf1b05417f45e89b8268af4858e1c9-620x480.jpg","twitter_misc":{"Written by":"info","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/#article","isPartOf":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/"},"author":{"name":"info","@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/#\/schema\/person\/6a0a5d2e1a48d29297b62e635a4db33f"},"headline":"Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine","datePublished":"2023-10-14T13:36:35+00:00","mainEntityOfPage":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/"},"wordCount":363,"commentCount":0,"image":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/#primaryimage"},"thumbnailUrl":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2017\/1\/A_doctor_makes_a_vaccination_to_a_child-Yuganov_Konstantin_cdbf1b05417f45e89b8268af4858e1c9-620x480.jpg","keywords":["announce","approval","Australia","BioNTech","COVID19","monovalent","Omicron","Pfizer","TGA","vaccine","XBB.1.5adapted"],"articleSection":["Blog"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/","url":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/","name":"Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine - Daniels Marketing BLC","isPartOf":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/#website"},"primaryImageOfPage":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/#primaryimage"},"image":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/#primaryimage"},"thumbnailUrl":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2017\/1\/A_doctor_makes_a_vaccination_to_a_child-Yuganov_Konstantin_cdbf1b05417f45e89b8268af4858e1c9-620x480.jpg","datePublished":"2023-10-14T13:36:35+00:00","author":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/#\/schema\/person\/6a0a5d2e1a48d29297b62e635a4db33f"},"description":"Pfizer Australia and BioNTech SE today announced that the Therapeutic Goods Administration (TGA) have authorized the businesses\u2019 XBB.1.5-adapted","breadcrumb":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/#primaryimage","url":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2017\/1\/A_doctor_makes_a_vaccination_to_a_child-Yuganov_Konstantin_cdbf1b05417f45e89b8268af4858e1c9-620x480.jpg","contentUrl":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2017\/1\/A_doctor_makes_a_vaccination_to_a_child-Yuganov_Konstantin_cdbf1b05417f45e89b8268af4858e1c9-620x480.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/10\/14\/pfizer-australia-and-biontech-announce-tga-approval-for-omicron-xbb-1-5-adapted-monovalent-covid-19-vaccine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/"},{"@type":"ListItem","position":2,"name":"Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine"}]},{"@type":"WebSite","@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/#website","url":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/","name":"Daniels Marketing BLC","description":"All About Health &amp; Marketing","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/#\/schema\/person\/6a0a5d2e1a48d29297b62e635a4db33f","name":"info","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/387c3341fa426df253347bf8f03bf81e7c8355f511b0ffdb256b6fad73bc149c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/387c3341fa426df253347bf8f03bf81e7c8355f511b0ffdb256b6fad73bc149c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/387c3341fa426df253347bf8f03bf81e7c8355f511b0ffdb256b6fad73bc149c?s=96&d=mm&r=g","caption":"info"},"url":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/author\/info\/"}]}},"jetpack_featured_media_url":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2017\/1\/A_doctor_makes_a_vaccination_to_a_child-Yuganov_Konstantin_cdbf1b05417f45e89b8268af4858e1c9-620x480.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/posts\/35383","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/comments?post=35383"}],"version-history":[{"count":2,"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/posts\/35383\/revisions"}],"predecessor-version":[{"id":35386,"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/posts\/35383\/revisions\/35386"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/media\/35384"}],"wp:attachment":[{"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/media?parent=35383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/categories?post=35383"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/tags?post=35383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}